Evaluation of e-liquid toxicity using an open-source high-throughput screening assay

PLoS Biology

Volumn 16, Issue 3, 2018, Pages

  Sassano, M Flori ^a   Davis, Eric S ^a   Keating, James E ^b   Zorn, Bryan T ^a   Kochar, Tavleen K ^b   Wolfgang, Matthew C ^a   Glish, Gary L ^b   Tarran, Robert ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CINNAMALDEHYDE; GLYCEROL; NICOTINE; PROPYLENE GLYCOL; TRIACETIN; UNCLASSIFIED DRUG; VANILLIN; VEGETABLE GLYCERIN; FLAVORING AGENT;

A-549 CELL LINE; AIRWAY SMOOTH MUSCLE CELL; ARTICLE; CELL GROWTH; CELL VIABILITY; CHEMICAL COMPOSITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; ELECTRONIC CIGARETTE; EMBRYO; HEK293T CELL LINE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IONIZATION; MASS FRAGMENTOGRAPHY; MULTIDIMENSIONAL SCALING; BIOLOGY; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; EPITHELIUM CELL; HEK293 CELL LINE; TOXICITY TESTING;

CELL SURVIVAL; CELLS, CULTURED; COMPUTATIONAL BIOLOGY; ELECTRONIC NICOTINE DELIVERY SYSTEMS; EPITHELIAL CELLS; FLAVORING AGENTS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLYCEROL; HEK293 CELLS; HUMANS; NICOTINE; PROPYLENE GLYCOL; TOXICITY TESTS;

EID: 85045263832     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.2003904     Document Type: Article

References (65)

1. Kim KH, Kabir E, Jahan SA, Review of electronic cigarettes as tobacco cigarette substitutes: Their potential human health impact. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2016;34(4):262–75. doi: 10.1080/10590501.2016.1236604 27635466.
2. Geiser M, Kreyling WG, Deposition and biokinetics of inhaled nanoparticles. Part Fibre Toxicol. 2010;7:2. doi: 10.1186/1743-8977-7-2 20205860.
3. Chen J, Bullen C, Dirks K, A Comparative Health Risk Assessment of Electronic Cigarettes and Conventional Cigarettes. Int J Environ Res Public Health. 2017;14(4). doi: 10.3390/ijerph14040382 28379177.
4. McNeill A BL, Calder R, Hitchman SC, Hajek P, McRobbie H. E-cigarettes: an evidence update. Public Health England. 2015.
5. Bekki K, Uchiyama S, Ohta K, Inaba Y, Nakagome H, Kunugita N, Carbonyl compounds generated from electronic cigarettes. Int J Environ Res Public Health. 2014;11(11):11192–200. doi: 10.3390/ijerph111111192 25353061.
6. Ogunwale MA, Li M, Ramakrishnam Raju MV, Chen Y, Nantz MH, Conklin DJ, et al. Aldehyde Detection in Electronic Cigarette Aerosols. ACS Omega. 2017;2(3):1207–14. doi: 10.1021/acsomega.6b00489 28393137.
7. Cheng T, Chemical evaluation of electronic cigarettes. Tob Control. 2014;23Suppl 2:ii11–7. Epub 2014/04/16. doi: 10.1136/tobaccocontrol-2013-051482 24732157.
8. Brown CJ, Cheng JM, Electronic cigarettes: product characterisation and design considerations. Tob Control. 2014;23Suppl 2:ii4–10. doi: 10.1136/tobaccocontrol-2013-051476 24732162.
9. Breland A, Soule E, Lopez A, Ramoa C, El-Hellani A, Eissenberg T, Electronic cigarettes: what are they and what do they do?Ann N Y Acad Sci. 2017;1394(1):5–30. doi: 10.1111/nyas.12977 26774031.
10. Services USDoHaH. E-Cigarette Use Among Youth and Young Adults. A Report of the Surgeon General. In: Services USDoHaH, editor. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2016.
11. Schroeder MJ, Hoffman AC, Electronic cigarettes and nicotine clinical pharmacology. Tob Control. 2014;23Suppl 2:ii30–5. doi: 10.1136/tobaccocontrol-2013-051469 24732160.
12. Papaseit E, Farre M, Graziano S, Pacifici R, Perez-Mana C, Garcia-Algar O, et al. Monitoring nicotine intake from e-cigarettes: measurement of parent drug and metabolites in oral fluid and plasma. Clin Chem Lab Med. 2017;55(3):415–23. doi: 10.1515/cclm-2016-0405 27559692.
13. Davis B, Dang M, Kim J, Talbot P, Nicotine concentrations in electronic cigarette refill and do-it-yourself fluids. Nicotine Tob Res. 2015;17(2):134–41. doi: 10.1093/ntr/ntu080 24862971.
14. Fiume MZ, Cosmetic Ingredients Review Expert PFinal report on the safety assessment of triacetin. Int J Toxicol. 2003;22Suppl 2:1–10. 14555416.
15. Registry AfTSaD. ADDENDUM TO THE TOXICOLOGICAL PROFILE FOR PROPYLENE GLYCOL 2008. [Cited 18 September 2018]. https://www.atsdr.cdc.gov/toxprofiles/propylene_glycol_addendum.pdf.
16. Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, et al. Safety assessment of propylene glycol, tripropylene glycol, and PPGs as used in cosmetics. Int J Toxicol. 2012;31(5 Suppl):245S–60S. doi: 10.1177/1091581812461381 23064775.
17. Johnson W, Jr.Cosmetic Ingredient Review Expert PFinal report on the safety assessment of PEG-25 propylene glycol stearate, PEG-75 propylene glycol stearate, PEG-120 propylene glycol stearate, PEG-10 propylene glycol, PEG-8 propylene glycol cocoate, and PEG-55 propylene glycol oleate. Int J Toxicol. 2001;20Suppl 4:13–26. 11800049.
18. FDA. Title 21—Food and Drugs: Propylene Glycol 2016. [Cited 18 September 2018]. Section 184.1666. https://www.gpo.gov/fdsys/pkg/CFR-2016-title21-vol3/xml/CFR-2016-title21-vol3-sec184-1666.xml.
19. Egilman D, Mailloux C, Valentin C, Popcorn-worker lung caused by corporate and regulatory negligence: an avoidable tragedy. Int J Occup Environ Health. 2007;13(1):85–98. doi: 10.1179/107735207800244893 17427353.
20. Hubbs AF, Battelli LA, Goldsmith WT, Porter DW, Frazer D, Friend S, et al. Necrosis of nasal and airway epithelium in rats inhaling vapors of artificial butter flavoring. Toxicol Appl Pharmacol. 2002;185(2):128–35. 12490137.
21. Rowell TR, Sizer S, Tarran R, Flavored E-Liquids Alter Cell Proliferation And Calcium Signaling. Am J Resp Crit Care. 2016;193.
22. Behar RZ, Davis B, Wang Y, Bahl V, Lin S, Talbot P, Identification of toxicants in cinnamon-flavored electronic cigarette refill fluids. Toxicol In Vitro. 2014;28(2):198–208. 24516877.
23. Scheffler S, Dieken H, Krischenowski O, Aufderheide M, Cytotoxic Evaluation of e-Liquid Aerosol using Different Lung-Derived Cell Models. Int J Environ Res Public Health. 2015;12(10):12466–74. doi: 10.3390/ijerph121012466 26445056.
24. Sherwood CL, Boitano S, Airway epithelial cell exposure to distinct e-cigarette liquid flavorings reveals toxicity thresholds and activation of CFTR by the chocolate flavoring 2,5-dimethypyrazine. Respir Res. 2016;17(1):57. doi: 10.1186/s12931-016-0369-9 27184162.
25. Zhang JH, Chung TD, Oldenburg KR, A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen. 1999;4(2):67–73. doi: 10.1177/108705719900400206 10838414.
26. Ghosh A, Abdelwahab SH, Reeber SL, Reidel B, Marklew AJ, Garrison AJ, et al. Little Cigars are More Toxic than Cigarettes and Uniquely Change the Airway Gene and Protein Expression. Sci Rep. 2017;7:46239. Epub 2017/04/28. doi: 10.1038/srep46239 28447619.
27. Du X, Lu D, Daharsh ED, Yao A, Dewoody R, Yao JA, Dimethyl sulfoxide effects on hERG channels expressed in HEK293 cells. J Pharmacol Toxicol Methods. 2006;54(2):164–72. doi: 10.1016/j.vascn.2006.03.002 16782359.
28. Morgan SJ, Deshpande DA, Tiegs BC, Misior AM, Yan H, Hershfeld AV, et al. beta-Agonist-mediated relaxation of airway smooth muscle is protein kinase A-dependent. J Biol Chem. 2014;289(33):23065–74. Epub 2014/06/29. doi: 10.1074/jbc.M114.557652 24973219.
29. Panettieri RA, JrIsolation and culture of human airway smooth muscle cells. Methods Mol Med. 2001;56:155–60. Epub 2001/01/01. doi: 10.1385/1-59259-151-5:155 21336899.
30. Rowell TR, Reeber SL, Lee SL, Harris RA, Nethery RC, Herring AH, et al. Flavored E-cigarette Liquids Reduce Proliferation and Viability in the CALU3 Airway Epithelial Cell Line. Am J Physiol Lung Cell Mol Physiol. 2017:ajplung 00392 2016. doi: 10.1152/ajplung.00392.2016 28428175.
31. Davis ES, Sassano MF, Goodell H, Tarran R, E-Liquid Autofluorescence can be used as a Marker of Vaping Deposition and Third-Hand Vape Exposure. Sci Rep. 2017;7(1):7459. Epub 2017/08/09. doi: 10.1038/s41598-017-07862-w 28785072.
32. Manning HC, Lander A, McKinley E, Mutic NJ, Accelerating the development of novel molecular imaging probes: a role for high-throughput screening. J Nucl Med. 2008;49(9):1401–4. doi: 10.2967/jnumed.108.053009 18703594.
33. Fritzsche M, Mandenius CF, Fluorescent cell-based sensing approaches for toxicity testing. Anal Bioanal Chem. 2010;398(1):181–91. doi: 10.1007/s00216-010-3651-6 20354845.
34. Clapp PW, Pawlak EA, Lackey JT, Keating JE, Reeber SL, Glish GL, et al. Flavored E-cigarette Liquids and Cinnamaldehyde Impair Respiratory Innate Immune Cell Function. Am J Physiol Lung Cell Mol Physiol. 2017:ajplung 00452 2016. doi: 10.1152/ajplung.00452.2016 28495856.
35. Chen X, Sassano MF, Zheng L, Setola V, Chen M, Bai X, et al. Structure-functional selectivity relationship studies of beta-arrestin-biased dopamine D(2) receptor agonists. J Med Chem. 2012;55(16):7141–53. doi: 10.1021/jm300603y 22845053.
36. Kroeze WK, Sassano MF, Huang XP, Lansu K, McCorvy JD, Giguere PM, et al. PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome. Nat Struct Mol Biol. 2015;22(5):362–9. doi: 10.1038/nsmb.3014 25895059.
37. Behar RZ, Luo W, Lin SC, Wang Y, Valle J, Pankow JF, et al. Distribution, quantification and toxicity of cinnamaldehyde in electronic cigarette refill fluids and aerosols. Tob Control. 2016;25(Suppl 2):ii94–ii102. doi: 10.1136/tobaccocontrol-2016-053224 27633763.
38. Iskandar AR, Gonzalez-Suarez I, Majeed S, Marescotti D, Sewer A, Xiang Y, et al. A framework for in vitro systems toxicology assessment of e-liquids. Toxicol Mech Methods. 2016;26(6):389–413. doi: 10.3109/15376516.2016.1170251 27117495.
39. Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23(2):133–9. doi: 10.1136/tobaccocontrol-2012-050859 23467656.
40. Sosnowski TR, Kramek-Romanowska K, Predicted Deposition of E-Cigarette Aerosol in the Human Lungs. J Aerosol Med Pulm Drug Deliv. 2016;29(3):299–309. Epub 2016/02/26. doi: 10.1089/jamp.2015.1268 26907696.
41. Reidel B, Radicioni G, Clapp P, Ford AA, Abdelwahab S, Rebuli ME, et al. E-Cigarette Use Causes a Unique Innate Immune Response in the Lung Involving Increased Neutrophilic Activation and Altered Mucin Secretion. Am J Respir Crit Care Med. 2017. Epub 2017/10/21. doi: 10.1164/rccm.201708-1590OC 29053025.
42. Yaucher NE, Fish JT, Smith HW, Wells JA, Propylene glycol-associated renal toxicity from lorazepam infusion. Pharmacotherapy. 2003;23(9):1094–9. 14524641.
43. Doi AM, Roycroft JH, Herbert RA, Haseman JK, Hailey JR, Chou BJ, et al. Inhalation toxicology and carcinogenesis studies of propylene glycol mono-t-butyl ether in rats and mice. Toxicology. 2004;199(1):1–22. doi: 10.1016/j.tox.2003.12.020 15125995.
44. Blake DA, Whikehart DR, Yu H, Vogel T, Roberts DD, Common cryopreservation media deplete corneal endothelial cell plasma membrane Na+,K+ ATPase activity. Curr Eye Res. 1996;15(3):263–71. 8654106.
45. Morshed KM, Jain SK, McMartin KE, Acute toxicity of propylene glycol: an assessment using cultured proximal tubule cells of human origin. Fundam Appl Toxicol. 1994;23(1):38–43. 7958561.
46. Galbraith DA, Diacetyl and occupational bronchiolitis obliterans: Comments on Rose, CS: Early detection, clinical diagnosis and management of lung disease from exposure to diacetyl, toxicology (2017), https://doi.org/10.1016/j.tox.2017.03.019. Toxicology. 2017;392:155–7. Epub 2017/10/22. doi: 10.1016/j.tox.2017.10.009 29054810.
47. Galbraith DA, Weill D, Diacetyl and bronchiolitis obliterans. Am J Respir Crit Care Med. 2008;178(3):313; author reply -4. Epub 2008/07/25. doi: 10.1164/ajrccm.178.3.313a 18650571.
48. Palmer SM, Flake GP, Kelly FL, Zhang HL, Nugent JL, Kirby PJ, et al. Severe airway epithelial injury, aberrant repair and bronchiolitis obliterans develops after diacetyl instillation in rats. PLoS ONE. 2011;6(3):e17644. Epub 2011/04/06. doi: 10.1371/journal.pone.0017644 21464978.
49. van Rooy FG, Rooyackers JM, Prokop M, Houba R, Smit LA, Heederik DJ, Bronchiolitis obliterans syndrome in chemical workers producing diacetyl for food flavorings. Am J Respir Crit Care Med. 2007;176(5):498–504. Epub 2007/06/02. doi: 10.1164/rccm.200611-1620OC 17541015.
50. Neusch C, Runde D, Moser A, G proteins modulate D2 receptor-coupled K(ATP) channels in rat dopaminergic terminals. Neurochem Res. 2000;25(12):1521–6. Epub 2001/01/11. 11152380.
51. Smith PA, Williams BA, Ashcroft FM, Block of ATP-sensitive K+ channels in isolated mouse pancreatic beta-cells by 2,3-butanedione monoxime. Br J Pharmacol. 1994;112(1):143–9. Epub 1994/05/01. 8032636.
52. Kiwamoto R, Ploeg D, Rietjens IM, Punt A, Dose-dependent DNA adduct formation by cinnamaldehyde and other food-borne alpha,beta-unsaturated aldehydes predicted by physiologically based in silico modelling. Toxicol In Vitro. 2016;31:114–25. doi: 10.1016/j.tiv.2015.11.014 26612355.
53. Premkumar LS, Transient receptor potential channels as targets for phytochemicals. ACS Chem Neurosci. 2014;5(11):1117–30. doi: 10.1021/cn500094a 24926802.
54. Berridge MJ, Bootman MD, Roderick HL, Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol. 2003;4(7):517–29. doi: 10.1038/nrm1155 12838335.
55. Azzopardi D, Patel K, Jaunky T, Santopietro S, Camacho OM, McAughey J, et al. Electronic cigarette aerosol induces significantly less cytotoxicity than tobacco smoke. Toxicol Mech Methods. 2016;26(6):477–91. doi: 10.1080/15376516.2016.1217112 27690199.
56. Taylor M, Carr T, Oke O, Jaunky T, Breheny D, Lowe F, et al. E-cigarette aerosols induce lower oxidative stress in vitro when compared to tobacco smoke. Toxicol Mech Methods. 2016;26(6):465–76. doi: 10.1080/15376516.2016.1222473 27690198.
57. Fulcher ML, Gabriel S, Burns KA, Yankaskas JR, Randell SH, Well-differentiated human airway epithelial cell cultures. Methods Mol Med. 2005;107:183–206. Epub 2004/10/20. 15492373.
58. Lubamba BA, Jones LC, O’Neal WK, Boucher RC, Ribeiro CM, X-Box-Binding Protein 1 and Innate Immune Responses of Human Cystic Fibrosis Alveolar Macrophages. Am J Respir Crit Care Med. 2015;192(12):1449–61. Epub 2015/09/04. doi: 10.1164/rccm.201504-0657OC 26331676.
59. Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L, Nicotine levels in electronic cigarettes. Nicotine Tob Res. 2013;15(1):158–66. doi: 10.1093/ntr/nts103 22529223.
60. Lee YH, Gawron M, Goniewicz ML, Changes in puffing behavior among smokers who switched from tobacco to electronic cigarettes. Addict Behav. 2015;48:1–4. doi: 10.1016/j.addbeh.2015.04.003 25930009.
61. Lopez AA, Hiler MM, Soule EK, Ramoa CP, Karaoghlanian NV, Lipato T, et al. Effects of Electronic Cigarette Liquid Nicotine Concentration on Plasma Nicotine and Puff Topography in Tobacco Cigarette Smokers: A Preliminary Report. Nicotine Tob Res. 2016;18(5):720–3. doi: 10.1093/ntr/ntv182 26377515.
62. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest. 2002;109(3):317–25. Epub 2002/02/06. doi: 10.1172/JCI13870 11827991.
63. Team RCR: A language and environment for statistical computing. R Foundation for Statistical Computing2017. [Cited 12 July 2017]. https://www.R-project.org/.
64. Oksanen J. B FG, Friendly M., Kindt R., Legendre P., McGlinn D., Minchin P.R., O’Hara R. B., Gavin L. Simpson G.L., Solymos P., Stevens M.H., Szoecs E., Wagner H. Vegan: Community Ecology Package. R package version 2.4–3. 2017. [Cited 12 July 2017]. https://CRAN.R-project.org/package=vegan.
65. Weihs C, Ligges U., Luebke K., Raabe N., Baier D, Decker R., Schmidt-Thieme L., klaR Analyzing German Business Cycles. In: Data Analysis and Decision Support. Berlin: Springer-Verlag; 2005. p. 335–43.